miRNAsong: a web-based tool for generation and testing of miRNA sponge constructs in silico
暂无分享,去创建一个
[1] Peter T Nelson,et al. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. , 2007, Molecular genetics and metabolism.
[2] Juyoung Ham,et al. MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions , 2016, Molecules and cells.
[3] S. Muljo,et al. Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases , 2015, The Journal of Immunology.
[4] H. Iba,et al. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells , 2009, Nucleic acids research.
[5] G. Pan,et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.
[6] P. Ismail,et al. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. , 2015, Pharmacological research.
[7] R. Giegerich,et al. Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.
[8] R. Lo,et al. The cumate gene-switch: a system for regulated expression in mammalian cells , 2006 .
[9] A. Ganser,et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function , 2007, Nucleic acids research.
[10] Sam Griffiths-Jones,et al. The microRNA Registry , 2004, Nucleic Acids Res..
[11] A. Garnier,et al. High‐level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene‐switch , 2010, Biotechnology and bioengineering.
[12] N. Wu,et al. MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer , 2014, Technology in cancer research & treatment.
[13] Ana Kozomara,et al. miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..
[14] L. Kiesel,et al. MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. , 2013, Fertility and sterility.
[15] Yi Jing,et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs , 2015, Proceedings of the National Academy of Sciences.
[16] Phillip A Sharp,et al. MicroRNA sponges: progress and possibilities. , 2010, RNA.
[17] George Coukos,et al. Therapeutic MicroRNA Strategies in Human Cancer , 2009, The AAPS Journal.
[18] R. Bak,et al. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. , 2013, RNA.
[19] M. Mraz,et al. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex , 2014, Leukemia.
[20] R. Bak,et al. Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors , 2013, RNA biology.
[21] J. SantaLucia,et al. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] William A. Rennie,et al. CLIP-based prediction of mammalian microRNA binding sites , 2013, Nucleic acids research.
[23] Peng Wang,et al. miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs , 2015, Database J. Biol. Databases Curation.
[24] Y. Shao,et al. MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6 , 2013, Cancer Cell International.
[25] Hailong Wu,et al. p53 represses c-Myc through induction of the tumor suppressor miR-145 , 2009, Proceedings of the National Academy of Sciences.
[26] Li Liu,et al. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer , 2015, Tumor Biology.
[27] G. Calin,et al. MicroRNAs in cancer therapeutics: “from the bench to the bedside” , 2015, Expert opinion on biological therapy.
[28] C. Rodrigues,et al. MicroRNA‐145 Regulates Neural Stem Cell Differentiation Through the Sox2–Lin28/let‐7 Signaling Pathway , 2016, Stem cells.
[29] Ales Hampl,et al. MicroRNAs Regulate p21Waf1/Cip1 Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells , 2012, Stem cells.
[30] V. Athyros,et al. Is Targeting microRNAs the Philosopher's Stone for Vascular Disease? , 2015, Current vascular pharmacology.
[31] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[32] C. Esau,et al. Inhibition of microRNA with antisense oligonucleotides. , 2008, Methods.
[33] Wenfang S. Wu,et al. A PCR-after-ligation method for cloning of multiple DNA inserts. , 2010, Analytical biochemistry.
[34] Ivo L. Hofacker,et al. Vienna RNA secondary structure server , 2003, Nucleic Acids Res..
[35] Wei Guo,et al. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. , 2012, Oncology reports.
[36] Tao Sun,et al. An Optimized Sponge for microRNA miR-9 Affects Spinal Motor Neuron Development in vivo , 2011, Front. Neurosci..
[37] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[38] Jan Krüger,et al. RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..
[39] A. Schier,et al. Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430 , 2007, Science.
[40] Michael Kertesz,et al. The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.
[41] Š. Pospíšilová,et al. EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS MicroRNAs Regulate p21 Waf1/Cip1 Protein Expression and the DNA Damage Response in Human Embryonic Stem Cells , 2012 .
[42] D. Montaner,et al. Brief Report: Inhibition of miR‐145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells , 2015, Stem cells.
[43] Grace X. Y. Zheng,et al. MicroRNAs can generate thresholds in target gene expression , 2011, Nature Genetics.
[44] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[45] Ye Ding,et al. Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition , 2012, PloS one.
[46] A. van den Berg,et al. Generation of miRNA sponge constructs. , 2012, Methods.
[47] R. Jain,et al. RNA interference-based therapeutics: molecular platforms for infectious diseases. , 2014, Journal of biomedical nanotechnology.
[48] K. Lee,et al. MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts. , 2016, International journal of cardiology.
[49] S. Kauppinen,et al. Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.
[50] Luigi Naldini,et al. Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.
[51] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..